Company / Operating Cash Flow per Share
Arcadia Biosciences, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$7.05
FY2025
5-year range
-$46.64 / -$2.25
FY2021-FY2025
Trend
+40.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-46.64 in FY2022 to $-7.05 in FY2025.
Based on SEC 10-K filings.
-7.05 in FY2025.
Improved from $-22.69 to $-7.05 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 40.7% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.05 | +40.7% |
| FY2024 | -$11.90 | +47.6% |
| FY2023 | -$22.69 | +51.4% |
| FY2022 | -$46.64 | -1976.2% |
| FY2021 | -$2.25 | -12.9% |
| FY2020 | -$1.99 | +30.3% |
| FY2019 | -$2.85 | +56.4% |
| FY2018 | -$6.54 | +14.7% |
| FY2017 | -$7.67 | -2142.2% |
| FY2016 | -$0.34 | +95.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026